Ping An Biomedical Co., Ltd. (PASW) — Cash Flow-to-Debt Ratio
Ping An Biomedical Co., Ltd. (PASW) has a Cash Flow-to-Debt Ratio of -0.28x as of September 2025, meaning its operating cash flow of $-6.43 Million could theoretically repay 0% of its total liabilities ($23.17 Million) in one year. Check Ping An Biomedical Co., Ltd. total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ping An Biomedical Co., Ltd. Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Ping An Biomedical Co., Ltd. across 5 annual periods. Also explore PASW total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ping An Biomedical Co., Ltd. (2021–2025)
Year-by-year debt coverage analysis for Ping An Biomedical Co., Ltd.. For market capitalisation and broader financial context, see PASW market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-6.43 Million | $23.17 Million | ▼ -221.4% |
| 2024 | 0.23x | $14.63 Million | $64.04 Million | ▲ +421.9% |
| 2023 | -0.07x | $-6.08 Million | $85.70 Million | ▼ -126.0% |
| 2022 | 0.27x | $21.09 Million | $77.35 Million | ▲ +165.8% |
| 2021 | -0.41x | $-31.37 Million | $75.77 Million | — |